Healthcare>Healthcare>Healthcare Services>Healthcare Research Analytics & Technology
₹420.35
4.95 (1.19%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹16.94K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
53.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Research Analytics & Technology
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹380+10.6%
52W High₹728.6-42.3%
Current Price
₹420.35
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹336.28
Upper Circuit₹504.42
Reference Price
₹420.35
Investment Checklist
Triple Top on 1D — target ₹362.1
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -57.64 (STRONG_SELL) with 83.6% confidence
Volume divergence: Bullish (price down, volume up)
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
84%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
433.45
EMA50
440.37
EMA200
517.28
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹427.83
₹450.51
₹463.80
₹512.95
₹518.55
Support (Below)
₹417.45
₹387.05
₹380.00
Volume Analysis
TrendINCREASING
Change+34.80%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹416.15
3% Risk₹407.74
5% Risk₹399.33
7% Risk (Custom)
₹390.93Technical Levels
1x ATR (Volatility)₹406.46
2x ATR (Swing)₹392.57
3x ATR (Trend)₹378.68
Immediate Support₹417.45
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹943.7 Cr | ₹888.4 Cr | ₹874.5 Cr | ₹917.1 Cr |
| Net Profit | ₹131.1 Cr | ₹183.3 Cr | ₹86.7 Cr | ₹15 Cr |
| EPS | ₹3.27 | — | ₹2.16 | ₹0.37 |
| Operating Profit | ₹301.9 Cr | ₹358.6 Cr | ₹224.1 Cr | ₹154 Cr |
Peer Comparison
Healthcare Research Analytics & TechnologyPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Syngene International Limited | ₹420.35 | +1.19% | 53.0 | ₹16.94K Cr small Cap | |
| Indegene Limited | ₹509.30 | +2.69% | 29.8 | ₹12.25K Cr small Cap | |
| Suven Life Sciences Limited | ₹357.85 | +3.20% | — | ₹8.14K Cr small Cap | |
| Vimta Labs Limited | ₹566.10 | +1.29% | 32.2 | ₹2.53K Cr small Cap | |
| Take Solutions Limited | ₹22.66 | -4.02% | 88.9 | ₹335 Cr small Cap | |
| Bilcare Limited | ₹63.06 | -2.40% | — | ₹148 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 25 Jun 2026 | Dividend - Rs 1.25 Per Share | DIVIDEND |
| 27 Jun 2025 | Dividend - Rs 1.25 Per Share | DIVIDEND |
| 28 Jun 2024 | Dividend - Rs 1.25 Per Share | DIVIDEND |
| 30 Jun 2023 | Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share | SPECIAL_DIVIDEND |
| 30 Jun 2022 | Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
| Date | Purpose | Type |
|---|---|---|
| 29 Jul 2026 | Financial Results | RESULTS |
Latest News
News for SYNGENE
View All
negative
ET Markets - Industry 7d ago
Syngene International MD & CEO Peter Bains resigns
Bains has resigned from the position of MD & CEO with effect from the close of business hours on June 30, Syngene International said in a regulatory filing.
SYNGENEHealthcare
NEWS
neutral
Business Standard - Markets 9d ago
Syngene International appoints Siddharth Mittal as MD & CEO
Syngene International announced that Siddharth Mittal has assumed charge as the company's managing director (MD) and chief executive officer (CEO) with effect from 1 July 2026.
MITTALSYNGENEHealthcareTextiles
positive
NDTV Profit 16d ago
Stock Picks Today: SBI, HDFC AMC, Nestle, Hero Moto, Kajaria, Syngene, Concord Biotech, And More On Brokerages' Radar
Brokerages' Radar
CONCORDBIONESTLEINDSYNGENEFast Moving Consumer GoodsHealthcare